Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-C in Osteoarthritis of the Knee
NCT03203330Phase 3Active, not recruiting
- Sponsor
- Kolon TissueGene, Inc.
- Start
- Oct 2018
- Primary completion
- Jul 2024
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Invossa in osteoarthritis (OA), sponsored by Kolon TissueGene, Inc.. Started Oct 2018; status: active, not recruiting.
02
Drugs
Invossa
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03203330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03203330.